News - NLSDays - NLSDays

Latest news in cooperation with Nordic Life Science

BioPorto and SDU collaborate on COVID-19 testing

1 April 2020 | 1:45 pm

BioPorto Diagnostics and University of Southern Denmark (SDU) develops COVID-19 test for early detection of infected patients to improve patient outcome and epidemic control. In this collaboration, Associate Professor Jonas Heilskov Graversen and Associate Professor Yaseelan Palarasah from SDU are leading the development of SARS-CoV-2 antibodies which will be introduced on BioPorto’s technology Generic Rapid […]

SynAct investigates AP1189 as additional therapy in hospitalized patients with COVID-19

31 March 2020 | 7:29 am

SynAct Pharma investigates the possibility of developing its clinical anti-inflammatory lead candidate drug AP1189 as an additional therapy in hospitalized patients with COVID-19 infection, to prevent Acute Respiratory Distress Syndrome (ARDS). SynAct intends to explore the possibility of applying AP1189 to clinics through potential funding from government institutions and commercial partners operating in the COVID-19 […]

The best in life science imaging has been awarded

31 March 2020 | 7:06 am

Olympus has announced the winners of its first Global Image of the Year Life Science Light Microscopy Award, a competition that recognizes the best in life science imaging worldwide. Ainara Pintor from Spain was selected as the global winner for her vibrant image of an immunostained mouse brain slice with two fluorophores. She named her […]

Peter Suenaert to resume his role as CMO at Immunicum

31 March 2020 | 6:22 am

Peter Suenaert will resume the role of Chief Medical Officer (CMO) at Immunicum effective May 1st, 2020. As CMO, he will be responsible for the clinical development and strategy for testing ilixadencel in patients with cancer. Due to personal reasons, Suenaert had left this role in Q3 2019 following the completion of the MERECA trial. […]

Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine

30 March 2020 | 8:53 am

Cobra Biologics and the Karolinska Institutet have announced they have been awarded €3 million emergency funding by Horizon 2020 for research and development, and phase I clinical trial testing of a DNA vaccine against COVID-19. The project is part of the OPENCORONA consortium to support global efforts tackling the pandemic. Partners in the consortium also […]

AstraZeneca’s Imfinzi approved in the US for extensive small cell lung cancer

30 March 2020 | 6:50 am

AstraZeneca’s Imfinzi has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide). The approval by the Food and Drug Administration was based on positive results from the Phase III CASPIAN trial showing […]

COVID-19: Norwegian patients are part of a historic clinical study

29 March 2020 | 2:45 pm

Norwegian hospitals are part of an international study with the purpose of determining which existing medicines are most effective against Covid-19. The World Health Organization (WHO) has launched a multiarm, multicountry clinical trial for potential coronavirus therapies, part of an effort to jumpstart the global search for drugs to treat Covid-19. The SOLIDARITY trial The […]

Karolinska Institutet receives a 9.4 million SEK donation from Nordstjernan

28 March 2020 | 12:20 pm

Karolinska Institutet has received a donation aimed for research that provides an immediate benefit in treating COVID-19 and also for the development of a biobank, useful for studies both now and in the future. “This donation enables groundbreaking research within the medical field that is most critical today. In addition it deepens existing and important […]

Strengthening healthcare capacity in virus diagnostics

28 March 2020 | 11:58 am

Through cooperation with a Chinese supplier, financial support from the Knut and Alice Wallenberg Foundation and coordination with the healthcare sector, Karolinska Institutet (KI) aims to strengthen healthcare capacity in virus diagnostics. Karolinska Institutet’s capabilities are now being coordinated with the healthcare sector’s resources for COVID-19 diagnostics. The coordination is taking place through a collaboration […]

Rapid test for COVID-19 is being developed in Turku

26 March 2020 | 6:04 pm

Finnish diagnostic company ArcDia is developing a test for COVID-19, for the use of healthcare. ArcDia has developed apparatus for diagnosing different infections for example respiratory infectious diseases, and the same test method can be used for the new coronavirus. Nordic Life Science asked the CEO of ArcDia, Vesa Kemppainen, about the method and its […]

Latest news in cooperation with Nordic Life Science

BioPorto and SDU collaborate on COVID-19 testing

SynAct investigates AP1189 as additional therapy in hospitalized patients with COVID-19

The best in life science imaging has been awarded

Peter Suenaert to resume his role as CMO at Immunicum

Cobra Biologics and the Karolinska Institutet collaborate to develop COVID-19 vaccine

AstraZeneca’s Imfinzi approved in the US for extensive small cell lung cancer

COVID-19: Norwegian patients are part of a historic clinical study

Karolinska Institutet receives a 9.4 million SEK donation from Nordstjernan

Strengthening healthcare capacity in virus diagnostics

Rapid test for COVID-19 is being developed in Turku

Join the conference!

Join the conference!

© 2020 Bionordic. All Rights Reserved
Legal Notices

Latest news in cooperation with Nordic Life Science

Join the conference!

© 2020 Bionordic. All Rights ReservedLegal Notices

© 2020 Bionordic. All Rights Reserved
Legal Notices